Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) Other Operating Expenses (2020 - 2026)

Updated

Xeris Biopharma Holdings' Other Operating Expenses came in at $18.62 million for Q2 2026, up 24.7% from $14.94 million a year earlier and up 25.6% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Other Operating Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Xeris Biopharma Holdings reported Other Operating Expenses of $61.03 million, up 20.0% year-over-year; for FY2025, it came in at $54.16 million, up 30.5% from FY2024.

  • Other Operating Expenses carries a five-year compound annual growth rate of 24.5% (FY2020 to FY2025).
  • Going back by year, Other Operating Expenses was $41.51 million in FY2024 (+23.0%), $33.73 million in FY2023 (-13.4%), $38.94 million in FY2022 (+27.7%) and $30.5 million in FY2021 (+68.7%).
  • The Q2 2026 figure represents the highest quarterly Other Operating Expenses in data going back to Q3 2020.
  • Year-over-year, Other Operating Expenses has increased for three consecutive quarters, with growth averaging 33.9% over the last eight quarters.
  • The fastest year-over-year change in Other Operating Expenses over five years came in Q1 2022 (growth of 206.2%), and the weakest in Q1 2023 (a decline of 44.8%).
  • Business Quant data shows XERS's Other Operating Expenses at $14.83 million (Q1 2026), $14.03 million (Q4 2025) and $13.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 15.14 Mn
Jun 30, 2026 15.22 Mn
Mar 31, 2026 13.28 Mn
Sep 30, 2024 -420,000.00
Jun 30, 2024 -601,000.00
Mar 31, 2024 -3.37 Mn
Dec 31, 2023 -2.13 Mn
Sep 30, 2023 -932,000.00
Jun 30, 2023 -781,000.00
Mar 31, 2023 -1.36 Mn
Dec 31, 2022 -4.41 Mn
Sep 30, 2022 -118,000.00
Jun 30, 2022 4.87 Mn
Mar 31, 2022 2.82 Mn
Dec 31, 2020 9.33 Mn
API Access

Xeris Biopharma Holdings Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=XERS&period=max&api_key=YOUR_API_KEY